BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Treatment
25 results:

  • 1. Association of systemic inflammatory markers and tertiary lymphoid structure with pathological complete response in gastric cancer patients receiving preoperative treatment: a retrospective cohort study.
    Wu Y; Zhao J; Wang Z; Liu D; Tian C; Ye B; Sun Y; Li H; Wang X
    Int J Surg; 2023 Dec; 109(12):4151-4161. PubMed ID: 38259000
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Total Versus Subtotal Gastrectomy for Distal gastric Poorly Cohesive Carcinoma.
    Boubaddi M; Teixeira Farinha H; Lambert C; Pereira B; Piessen G; Gualtierotti M; Voron T; Mantziari S; Pezet D; Gronnier C;
    Ann Surg Oncol; 2024 Feb; 31(2):744-752. PubMed ID: 37971616
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. SMARCA4 and SMARCE1 in gastric cancer: Correlation with ARID1A, and microsatellite stability, and SMARCE1/ERBB2 co-amplification.
    Pries K; Krüger S; Heckl S; Behrens HM; Röcken C
    Cancer Med; 2023 May; 12(9):10423-10437. PubMed ID: 36916408
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Investigation on the cellular mechanism of Prunetin evidenced through next generation sequencing and bioinformatic approaches against gastric cancer.
    Vetrivel P; Nachimuthu S; Abuyaseer A; Bhosale PB; Ha SE; Kim HH; Park MY; Kim GS
    Sci Rep; 2022 Jul; 12(1):11852. PubMed ID: 35831348
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world study.
    Li PC; Huang RY; Yang YC; Hsieh KP; Yang YH
    BMC Cancer; 2022 Apr; 22(1):430. PubMed ID: 35443635
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Incidence and risk factors for postoperative pancreatic fistula in 2089 patients treated by radical gastrectomy: A prospective multicenter cohort study in China.
    Wu J; Tang Z; Zhao G; Zang L; Li Z; Zang W; Li Z; Qu J; Yan S; Zheng C; Ji G; Zhu L; Zhao Y; Zhang J; Huang H; Hao Y; Fan L; Xu H; Li Y; Yang L; Song W; Zhu J; Zhang W; Li M; Qin X; Liu F
    Int J Surg; 2022 Feb; 98():106219. PubMed ID: 34990829
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prediction of Severe Cisplatin-Induced Neutropenia Using Serum Albumin Concentration-A Retrospective Study.
    Nakazawa Y; Kageyama A; Kitamura M; Mitsumori N; Kawakubo T
    Gan To Kagaku Ryoho; 2021 Aug; 48(8):1037-1042. PubMed ID: 34404072
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer.
    Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z
    Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer.
    Park SE; Choi JH; Park JY; Kim BJ; Kim JG; Kim JW; Park JM; Chi KC; Hwang IG
    Sci Rep; 2020 Oct; 10(1):17683. PubMed ID: 33077864
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Effects of Guidelines for Gastroenterological Endoscopy in Patients Undergoing Antithrombotic treatment on Postoperative Bleeding after Endoscopic Submucosal Dissection for Early gastric cancer: A Propensity Score-Matching Analysis.
    Terasaki K; Dohi O; Naito Y; Azuma Y; Ishida T; Kitae H; Matsumura S; Ogita K; Takayama S; Mizuno N; Nakano T; Iwai N; Ueda T; Hirose R; Inoue K; Yoshida N; Kamada K; Uchiyama K; Ishikawa T; Takagi T; Konishi H; Itoh Y
    Digestion; 2021; 102(2):256-264. PubMed ID: 31770748
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
    Moore KN; Secord AA; Geller MA; Miller DS; Cloven N; Fleming GF; Wahner Hendrickson AE; Azodi M; DiSilvestro P; Oza AM; Cristea M; Berek JS; Chan JK; Rimel BJ; Matei DE; Li Y; Sun K; Luptakova K; Matulonis UA; Monk BJ
    Lancet Oncol; 2019 May; 20(5):636-648. PubMed ID: 30948273
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus.
    Tseng CH
    Metabolism; 2018 Aug; 85():223-226. PubMed ID: 29729227
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Recurrence Pattern and Lymph Node Metastasis of Adenocarcinoma at the Esophagogastric Junction.
    Suh YS; Lee KG; Oh SY; Kong SH; Lee HJ; Kim WH; Yang HK
    Ann Surg Oncol; 2017 Nov; 24(12):3631-3639. PubMed ID: 28828728
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The effect of chemotherapy-induced anemia on dose reduction and dose delay.
    Family L; Xu L; Xu H; Cannavale K; Sattayapiwat O; Page JH; Bohac C; Chao C
    Support Care Cancer; 2016 Oct; 24(10):4263-71. PubMed ID: 27167627
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study.
    Shi H; Han J; Yue S; Zhang T; Zhu W; Zhang D
    Biomed Pharmacother; 2015 Apr; 71():210-5. PubMed ID: 25960238
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Relationship between p53 status and response to chemotherapy in patients with gastric cancer: a meta-analysis.
    Xu HY; Xu WL; Wang LQ; Chen MB; Shen HL
    PLoS One; 2014; 9(4):e95371. PubMed ID: 24740294
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Feasibility and functional efficacy of distal gastrectomy with jejunal interposition for gastric cancer: a case series.
    Ninomiya S; Arita T; Sonoda K; Bandoh T; Shiroshita H; Tajima M
    Int J Surg; 2014; 12(5):56-9. PubMed ID: 24200755
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer.
    Koizumi W; Yamaguchi K; Hosaka H; Takinishi Y; Nakayama N; Hara T; Muro K; Baba H; Sasaki Y; Nishina T; Fuse N; Esaki T; Takagi M; Gotoh M; Sasaki T
    Br J Cancer; 2013 Oct; 109(8):2079-86. PubMed ID: 24045669
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comparison of the clinicopathological characteristics and results of endoscopic submucosal dissection for esophagogastric junction and non-junctional cancers.
    Hoteya S; Matsui A; Iizuka T; Kikuchi D; Yamada A; Yamashita S; Furuhata T; Domon K; Nakamura M; Mitani T; Ogawa O; Kasie M
    Digestion; 2013; 87(1):29-33. PubMed ID: 23343966
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prognosis of curatively resected pT4b gastric cancer with respect to invaded organ type.
    Min JS; Jin SH; Park S; Kim SB; Bang HY; Lee JI
    Ann Surg Oncol; 2012 Feb; 19(2):494-501. PubMed ID: 21837527
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.